Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01367132 · ClinicalTrials.gov registry record

Assessment of the Number of Umbilical Cord Vessels at the Time of Nuchal Translucency Screening

A clinical trial of Umbilical Cord, sponsored by Medstar Health Research Institute.

Completed
Registry status
123
Enrollment target
2
Study locations

NCT01367132: Completed study of Umbilical Cord, sponsored by Medstar Health Research Institute.

NCT01367132 is a study of Umbilical Cord that has completed, run by Medstar Health Research Institute. The registered enrollment target is 123 participants. The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01367132, a study of Umbilical Cord, has completed, sponsored by Medstar Health Research Institute.

COMPLETED
Registry status
123 participants
Enrollment target
2
Study locations

Study Summary

The primary objective of this study is to determine the detection rate of two- or three-vessel umbilical cord at the time of nuchal translucency screening between 11 and 13 6/7 weeks gestation. Hypothesis: Detection rate of the number of vessels during first trimester will be as accurate as the detection of vessels during the second trimester.

Conditions Studied

Interventions

  • PROCEDURE Doppler ultrasound

Study Locations (2)

District of Columbia

  • Georgetown University Hospital, MedStar Health - Washington D.C.
  • Washington Hospital Center, MedStar Health - Washington D.C.

Trial Details

FieldValue
Enrollment Target 123 participants
Start Date 2011-02
Est. Completion 2013-01
Medstar Health Research Institute

115 total trials

What the finished NCT01367132 record still lists

NCT01367132 is an observational study that tracks outcomes without assigning an intervention. The registered 123 participants enrollment target is mid-sized for trials with a published cap.

The record links to 1 condition, with Umbilical Cord appearing as the primary indexed condition, and to 1 intervention - of which Doppler ultrasound is the first listed.

NCT01367132 reports a single indexed study location in District of Columbia.

Frequently Asked Questions

What is clinical trial NCT01367132 about?

NCT01367132 is a clinical study titled "Assessment of the Number of Umbilical Cord Vessels at the Time of Nuchal Translucency Screening". The primary objective of this study is to determine the detection rate of two- or three-vessel umbilical cord at the time of nuchal translucency screening between 11 and 13 6/7 weeks gestation. Hypothesis: Detection rate of the number of vessels during first trimester will be as accurate as the det...

What is the current status of trial NCT01367132?

This trial is currently completed. The enrollment target is 123 participants. The study started on 2011-02. Estimated completion is 2013-01.

What conditions does trial NCT01367132 study?

This clinical trial studies the following conditions: Umbilical Cord.

What interventions are being tested in trial NCT01367132?

The interventions under investigation include: Doppler ultrasound (PROCEDURE).

Who is sponsoring clinical trial NCT01367132?

This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01367132 being conducted?

This trial has 2 study locations across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Umbilical Cord

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05285891 · 123 participants · Phase 4

    Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis

  • NCT05334368 · 123 participants · Phase 3

    Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial

  • NCT06088355 · 123 participants · NA

    Moderate Versus High Volume Light-Moderate Intensity Exercise for People With Moderate Parkinson's Disease

  • NCT06111131 · 123 participants · NA

    Ancora-SB Overtube Complete Positioning and Optical Visualization During Endoscopic Procedures

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01367132, the US trial registry maintained by the National Library of Medicine. NCT01367132 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.